While Sight Sciences News Today

© 2021 Sight Sciences. All rights reserved. Forward-Looking Statements This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. When used herein, words including “anticipate,” “will,” and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterization...

Share: MENLO PARK, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devises that target the underlying causes of the worlds most prevalent eye diseases, today announced the pricing of its initial public offering of 10,000,000 shares of common stock at a public offering price of $24.00 per share. All shares of common stock are being offered by Sight Sciences for total gross proc...